JAK2 and breast cancer: A combinational therapy of MSM (200 mM) and tamoxifen was reported to inhibit breast cancer tumor growth and metastasis, both in vitro and in vivo by modulation of Jak2 and transducer and activator of transcription 5b (STAT5b) pathway.